Big Pharma’s raking in record profits while everyday Americans struggle to afford life-saving medicines. A new report shows drug companies pocket 23% profit margins—ten times higher than pharmacies and insurers. These greedy corporations blame everyone else for high prices, but their own price-gouging and patent tricks fuel the crisis.

Last year alone, Big Pharma made $800 billion in revenue. Giants like Eli Lilly and Novo Nordisk are seeing explosive growth, thanks to sky-high drug costs. Meanwhile, families skip doses or ration medications because they can’t pay. It’s clear who’s winning—and who’s suffering.

Foreign countries like Canada and Europe pay far less for the same drugs, sticking American patients with the bill. Global freeloaders exploit U.S. innovation without sharing costs. It’s time for these nations to pay their fair share and stop relying on American generosity.

Big Pharma owns the media and political class, silencing critics and protecting their monopoly. Corrupt lobbyists shower politicians with cash to block reforms. They’d rather fund attack ads than lower prices for seniors and veterans.

While pharmacies and insurers operate on slim 2% margins, drug companies swim in cash. Their CEO bonuses could fund clinics for a year. This isn’t about innovation—it’s about greed. They’re squeezing patients dry to please Wall Street.

Patriots know real innovation doesn’t require bankrupting families. Competition and transparency could slash prices overnight. But Big Pharma fights every reform, clinging to schemes that keep drugs unaffordable.

Hardworking Americans built this country’s medical breakthroughs. Now, we’re held hostage by executives who care more about profits than cures. It’s time to put America first and demand accountability.

The solution isn’t socialism—it’s fairness. Break monopolies, end patent abuses, and make global competitors pay up. Our lives shouldn’t be a stock market gamble for corporate fat cats. Freedom means affordable access to the medicines we need.